Literature DB >> 17645507

The influence of reproductive and hormonal factors on ovarian cancer survival.

C M Nagle1, C J Bain, A C Green, P M Webb.   

Abstract

Reproductive and hormonal exposures are known to influence ovarian carcinogenesis, but little is known about the effect of these factors on survival. We have studied survival according to hormonal and reproductive history in a population-based cohort of 676 Australian women aged 18-79, newly diagnosed with invasive epithelial ovarian cancer in the early 1990s. In order to place our findings in context, we have also undertaken a systematic review of the pertinent literature. Detailed information about each woman's reproductive and contraceptive history was obtained from pregnancy and contraceptive calendars at the time of diagnosis. Cox regression was used to obtain multivariate adjusted hazard ratios (HR) and 95% confidence intervals (CI). A total of 419 (62%) of the 676 women died during the follow-up (giving a 5-year survival proportion of 44%). Apart from better survival for women who had ever breastfed (multivariate HR 0.74, 95% CI 0.55-0.98), we found no association between survival from invasive ovarian cancer and a range of hormonal and gynecological factors including parity, use of oral contraceptives, and histories of tubal sterilization or hysterectomy. Systematic review of the literature generally supported the lack of influence of these factors on survival from ovarian cancer. We conclude that, except for a possible survival advantage among women with a history of breastfeeding, reproductive and hormonal exposures prior to diagnosis do not influence survival from invasive ovarian cancer, in contrast to their substantial effects on etiology of this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645507     DOI: 10.1111/j.1525-1438.2007.01031.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  13 in total

1.  Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.

Authors:  Nonna V Kolomeyevskaya; J Brian Szender; Gary Zirpoli; Albina Minlikeeva; Grace Friel; Rikki A Cannioto; Rachel M Brightwell; Kassondra S Grzankowski; Kirsten B Moysich
Journal:  Int J Gynecol Cancer       Date:  2015-11       Impact factor: 3.437

2.  Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.

Authors:  Katharine K Brieger; Siri Peterson; Alice W Lee; Bhramar Mukherjee; Kelly M Bakulski; Aliya Alimujiang; Hoda Anton-Culver; Michael S Anglesio; Elisa V Bandera; Andrew Berchuck; David D L Bowtell; Georgia Chenevix-Trench; Kathleen R Cho; Daniel W Cramer; Anna DeFazio; Jennifer A Doherty; Renée T Fortner; Dale W Garsed; Simon A Gayther; Aleksandra Gentry-Maharaj; Ellen L Goode; Marc T Goodman; Holly R Harris; Estrid Høgdall; David G Huntsman; Hui Shen; Allan Jensen; Sharon E Johnatty; Susan J Jordan; Susanne K Kjaer; Jolanta Kupryjanczyk; Diether Lambrechts; Karen McLean; Usha Menon; Francesmary Modugno; Kirsten Moysich; Roberta Ness; Susan J Ramus; Jean Richardson; Harvey Risch; Mary Anne Rossing; Britton Trabert; Nicolas Wentzensen; Argyrios Ziogas; Kathryn L Terry; Anna H Wu; Gillian E Hanley; Paul Pharoah; Penelope M Webb; Malcolm C Pike; Celeste Leigh Pearce
Journal:  Gynecol Oncol       Date:  2020-07-06       Impact factor: 5.482

3.  High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.

Authors:  Katharine K Brieger; Minh Tung Phung; Bhramar Mukherjee; Kelly M Bakulski; Hoda Anton-Culver; Elisa V Bandera; David D L Bowtell; Daniel W Cramer; Anna DeFazio; Jennifer A Doherty; Sian Fereday; Renée Turzanski Fortner; Aleksandra Gentry-Maharaj; Ellen L Goode; Marc T Goodman; Holly R Harris; Keitaro Matsuo; Usha Menon; Francesmary Modugno; Kirsten B Moysich; Bo Qin; Susan J Ramus; Harvey A Risch; Mary Anne Rossing; Joellen M Schildkraut; Britton Trabert; Robert A Vierkant; Stacey J Winham; Nicolas Wentzensen; Anna H Wu; Argyrios Ziogas; Lilah Khoja; Kathleen R Cho; Karen McLean; Jean Richardson; Bronwyn Grout; Anne Chase; Cindy McKinnon Deurloo; Kunle Odunsi; Brad H Nelson; James D Brenton; Kathryn L Terry; Paul D P Pharoah; Andrew Berchuck; Gillian E Hanley; Penelope M Webb; Malcolm C Pike; Celeste Leigh Pearce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-17       Impact factor: 4.090

4.  Dairy food and nutrient intake in different life periods in relation to risk of ovarian cancer.

Authors:  Melissa A Merritt; Elizabeth M Poole; Susan E Hankinson; Walter C Willett; Shelley S Tworoger
Journal:  Cancer Causes Control       Date:  2014-04-11       Impact factor: 2.506

5.  Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.

Authors:  Elizabeth M Poole; Melissa A Merritt; Susan J Jordan; Hannah P Yang; Susan E Hankinson; Yikung Park; Bernard Rosner; Penelope M Webb; Daniel W Cramer; Nicolas Wentzensen; Kathryn L Terry; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-10       Impact factor: 4.254

6.  Anthropometric measures and risk of epithelial ovarian cancer: results from the nurses' health study.

Authors:  Joanne Kotsopoulos; Heather J Baer; Shelley S Tworoger
Journal:  Obesity (Silver Spring)       Date:  2009-12-24       Impact factor: 5.002

7.  Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival.

Authors:  Aminah Jatoi; Nathan R Foster; Kimberly R Kalli; Robert A Vierkant; Zhiying Zhang; Melissa C Larson; Brooke Fridley; Ellen L Goode
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

8.  Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases.

Authors:  Amy L Shafrir; Ana Babic; Rulla M Tamimi; Bernard A Rosner; Shelley S Tworoger; Kathryn L Terry
Journal:  Br J Cancer       Date:  2016-10-04       Impact factor: 7.640

9.  Tubal ligation, hysterectomy and ovarian cancer: A meta-analysis.

Authors:  Megan S Rice; Megan A Murphy; Shelley S Tworoger
Journal:  J Ovarian Res       Date:  2012-05-15       Impact factor: 4.234

10.  Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.

Authors:  Jelena Bešević; Marc J Gunter; Renée T Fortner; Konstantinos K Tsilidis; Elisabete Weiderpass; N Charlotte Onland-Moret; Laure Dossus; Anne Tjønneland; Louise Hansen; Kim Overvad; Sylvie Mesrine; Laura Baglietto; Françoise Clavel-Chapelon; Rudolf Kaaks; Krasimira Aleksandrova; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Christina Bamia; Giovanna Masala; Claudia Agnoli; Rosario Tumino; Fulvio Ricceri; Salvatore Panico; H Bas Bueno-de-Mesquita; Petra H Peeters; Mie Jareid; J Ramón Quirós; Eric J Duell; María-José Sánchez; Nerea Larrañaga; María-Dolores Chirlaque; Aurelio Barricarte; Joana A Dias; Emily Sonestedt; Annika Idahl; Eva Lundin; Nicholas J Wareham; Kay-Tee Khaw; Ruth C Travis; Sabina Rinaldi; Isabelle Romieu; Elio Riboli; Melissa A Merritt
Journal:  Br J Cancer       Date:  2015-11-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.